Results 11 to 20 of about 446,603 (195)

Novel Treatments in Refractory Recurrent Pericarditis [PDF]

Pharmaceuticals
Refractory recurrent pericarditis is a troublesome condition that severely impairs the quality of life of affected patients and significantly increases healthcare spending.
Dimitris Tousoulis, Panagiotis Theofilis, Christos Koutsianas   +2 more
exaly   +6 more sources

Use of Anakinra in steroid dependent recurrent pericarditis: a case report and review of literature

Journal of Community Hospital Internal Medicine Perspectives, 2021
Non-steroidal anti-inflammatory drugs and colchicine are the cornerstone treatment for recurrent pericarditis. Corticosteroids are frequently used in patients with recurrent episodes of pericarditis.
Vinay Thallapally, Sonia Gupta
exaly   +3 more sources

Efficacy and Safety of Pharmaceutically Manufactured Cannabidiol in Recurrent Pericarditis: A Phase II Clinical Trial. [PDF]

J Am Heart Assoc
Background Recurrent pericarditis may be mediated through inappropriate activation of the NACHT, leucine‐rich repeat, and pyrin domain‐containing protein 3 inflammasome. Pharmaceutically manufactured cannabidiol is an oral formulation that inhibits NACHT,
Luis SA, Klein AL, Cremer PC, Abbate A, Salik JR, Thomas GK, Haider SW, Hagerty TE, Lin D, Waggoner TE, Nicholls SJ, Kirwan BA, Narine KAD, Parker AB, Hamer A.   +14 more
europepmc   +2 more sources

Management of Recurrent Pregnancy-Related Pericarditis [PDF]

Case Reports in Cardiology, 2022
The evidence on recurrent pregnancy-related pericarditis is limited, and management strategies are based on case reports and expert opinion. We describe a patient with myopericarditis complicated by cardiac tamponade presenting shortly after her first ...
Michel Ibrahim, Michael Fattouh, Alice Jacobs   +2 more
doaj   +3 more sources

US Database Study of Clinical Burden and Unmet Need in Recurrent Pericarditis

Journal of the American Heart Association, 2021
Background Patients with recurrent pericarditis (RP) may develop complications, multiple recurrences, or inadequate treatment response. This study aimed to characterize disease burden and unmet needs in RP.
Mike Roy, Michelle Z Lim-Watson
exaly   +3 more sources

Sex related differences in acute and recurrent pericarditis: A narrative review. [PDF]

Am Heart J Plus
Background: Acute and recurrent pericarditis represent significant clinical challenges, with growing evidence suggesting important sex-related differences in their presentation, etiology, and course.
Alanazi N.
europepmc   +2 more sources

Idiopathic recurrent pericarditis — a paradigm shift? [PDF]

Российский кардиологический журнал, 2019
Idiopathic recurrent  pericarditis (IRP) is a relatively rare inflammatory disease of the pericardium,  often  requiring  emergency medical  care,   associated with a  high percentage of temporary  disability and  significant  economic  costs.
V. Yu. Myachikova, V. A. Titov, A. L. Maslyanskiy, O. M. Moiseeva   +3 more
doaj   +2 more sources

Recurrent pericarditis: a case report and literature review

Acta Medica Lituanica, 2017
Background. Recurrence affects about 30% (20% to 50%) of patients within 18 months after the initial episode of acute pericarditis resulting in subsequent rehospitalizations.
Justina Katinaitė, Birutė Petrauskienė   +1 more
doaj   +2 more sources

Anakinra for constrictive pericarditis associated with incessant or recurrent pericarditis

Heart, 2020
Objective Frequent flares of pericardial inflammation in recurrent or incessant pericarditis with corticosteroid dependence and colchicine resistance may represent a risk factor for constrictive pericarditis (CP).
Andreis A., Imazio M., Giustetto C., Brucato A., Adler Y., De Ferrari G. M.   +5 more
openaire   +3 more sources

Autoinflammatory Recurrent Pericarditis Associated with a New NLRP12 Mutation in a Male Adolescent [PDF]

Life (Basel), 2023
Idiopathic recurrent pericarditis (IRP) can be the hallmark of an autoinflammatory syndrome with recurrent attacks of chest pain and symptom-free intervals following an acute episode. The recurrence rate may be 35% in the pediatric population, frequently
Cinteza E, Stefan D, Iancu M, Ioan A, Vasile C, Vatasescu R, Cochino A.   +6 more
europepmc   +2 more sources